The FGF23 and Klotho system beyond mineral metabolism

Makoto Kuro-o

Research output: Contribution to journalReview articlepeer-review

41 Scopus citations


FGF23 is a bone-derived hormone that acts primarily on the kidney to induce phosphaturia and suppress synthesis of 1,25-dihydroxyvitamin D3. The unique feature of FGF23 is that it requires Klotho as an obligate co-receptor. The FGF23–Klotho system has emerged as an endocrine axis indispensable for maintaining phosphate homeostasis. Mineral and bone disorders associated with chronic kidney disease (CKD-MBD) can be viewed as a series of events triggered by a compensatory response of the FGF23–Klotho system to excess phosphate intake relative to the residual nephron number. Furthermore, the fact that disruption of the FGF23–Klotho system causes phosphate retention and a syndrome resembling aging in mammals has led to the notion that phosphate accelerates aging. The aging-like pathology caused by phosphate, or phosphatopathy, may be unique to the higher organisms having the Klotho gene and provides new insights into the molecular mechanism of aging in humans.

Original languageEnglish (US)
Pages (from-to)64-69
Number of pages6
JournalClinical and Experimental Nephrology
StatePublished - Mar 1 2017


  • FGF23
  • Phosphatopathy
  • αKlotho

ASJC Scopus subject areas

  • Physiology
  • Nephrology
  • Physiology (medical)


Dive into the research topics of 'The FGF23 and Klotho system beyond mineral metabolism'. Together they form a unique fingerprint.

Cite this